Salmeterol/Fluticasonpropionat Devatis 25 μg/125 μg

Salmeterol/Fluticasonpropionat Devatis 25 μg/125 μg is a medicine authorised by Swissmedic under authorisation number 69903. The authorisation holder is Devatis AG. The medicinal product code is Synthetic medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 16 September 2025 and the authorisation is limited until 15 September 2030. ATC code R03AK06 places the medicine in the group Drugs for obstructive airway diseases.

  • Dispensing category B
  • Authorisation number 69903
  • ATC R03AK06
  • Synthetic medicines
Authorisation data
Authorisation number69903
NameSalmeterol/Fluticasonpropionat Devatis 25 μg/125 μg
Full nameSalmeterol/Fluticasonpropionat Devatis 25 μg/125 μg, Dosier-Aerosol
Authorisation holderDevatis AG
Medicinal product codeSynthetic medicines
Dispensing categoryB · Prescription only
ATC codeR03AK06
First authorisation16 September 2025
Authorisation validity15 September 2030
Strengths
No.NameDispensing categoryAuthorisation date
1Salmeterol/Fluticasonpropionat Devatis 25 μg/125 μg, Dosier-AerosolB16 September 2025
2Salmeterol/Fluticasonpropionat Devatis 25 μg/250 μg, Dosier-AerosolB16 September 2025

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
1120Einzeldose(n)R03AK0603.04.3.B
2120Einzeldose(n)R03AK0603.04.3.B

Scroll the table sideways

Medicines in the same ATC group

Other medicines from this authorisation holder

Frequently asked questions

Is Salmeterol/Fluticasonpropionat Devatis 25 μg/125 μg authorised in Switzerland?

Yes. Salmeterol/Fluticasonpropionat Devatis 25 μg/125 μg is authorised by Swissmedic under authorisation number 69903, data as of 01 September 2026. The authorisation is limited until 15 September 2030.

Which dispensing category does Salmeterol/Fluticasonpropionat Devatis 25 μg/125 μg have?

Salmeterol/Fluticasonpropionat Devatis 25 μg/125 μg is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Salmeterol/Fluticasonpropionat Devatis 25 μg/125 μg?

The authorisation holder is Devatis AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com